1-2 of 2
Nishitha M. Reddy, MBBS
Close
Sort by
Journal Articles

Hematologic and Immunologic Function and Patient Well-Being for the Phase III RESONATE TM Study of Ibrutinib Vs Ofatumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Jacqueline C. Barrientos, MD, Susan O'Brien, Jennifer R. Brown, MD PhD, Neil E. Kay, MD, Nishitha M. Reddy, MBBS, Steven Coutre, MD, Constantine Tam, MD, Stephen Mulligan, MBBS, MD FRACP, FRCPA, Ulrich Jaeger, MD, Steve Devereux, MD, Christopher Pocock, MD PhD, Tadeusz Robak, MD, Stephen J. Schuster, MD, Anna Schuh, MDPhD, Devinder Gill, MD, Adrian Bloor, PhD FRCPath, Claire Dearden, MD, Carol Moreno, MD, Gavin Cull, MBBS, DM, FRACP, FRCPA, Michael Hamblin, Jeffrey A. Jones, MD, Tanja Kierschniak, Karl Eckert, BA, Samuel Suzuki, MS, MBA, Emily Hsu, PhD, Danelle F. James, MD MAS, John C. Byrd, MD, Peter Hillmen, MB, ChB, PhD
Journal: Blood
Blood (2014) 124 (21): 4696.
https://doi.org/10.1182/blood.V124.21.4696.4696
Published: 2014
Journal Articles

Thyroid Dysfunction in Patients with Diffuse Large B-Cell Lymphoma Receiving Lenalidomide May be Mediated By TNF-α

Wade T Iams, MD, Megan L Hames, Judy Peih-Ying P Tsai, MD, Kimberly B Dahlman, PhD, Mahsa Talbott, PharmD, BCOP, Kristy L. Richards, MDPhD, Nishitha M. Reddy, MBBS
Journal: Blood
Blood (2014) 124 (21): 4438.
https://doi.org/10.1182/blood.V124.21.4438.4438
Published: 2014